Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients (2007)
- Authors:
- USP affiliated authors: ROCHA, DALVA MARREIRO - FM ; FUKUI, ROSA TSUNECHIRO - FM
- Unidade: FM
- Subjects: BIOMARCADORES; DIABETES MELLITUS (COMPLICAÇÕES); ANTICORPOS; AUTOANTICORPOS; RESUMOS (EVENTOS)
- Language: Português
- Imprenta:
- Publisher: Sociedade Brasileira de Endocrinologia e Metabologia - SBEM
- Publisher place: São Paulo
- Date published: 2007
- Source:
- Título do periódico: Arquivos Brasileiros de Endocrinologia & Metabologia
- ISSN: 0004-2730
- Volume/Número/Paginação/Ano: v. 51, n. 3, supl. 1, p. S101, 02.002, 2007
- Conference titles: Congresso Paulista de Endocrinologia e Metabolismo
-
ABNT
CRISOSTOMO, L. G. et al. Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients. Arquivos Brasileiros de Endocrinologia & Metabologia. São Paulo: Sociedade Brasileira de Endocrinologia e Metabologia - SBEM. . Acesso em: 19 set. 2024. , 2007 -
APA
Crisostomo, L. G., Gamberini, M., Locoseli, L., Danivi, E., Rocha, D. M., Alves, L. I., et al. (2007). Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients. Arquivos Brasileiros de Endocrinologia & Metabologia. São Paulo: Sociedade Brasileira de Endocrinologia e Metabologia - SBEM. -
NLM
Crisostomo LG, Gamberini M, Locoseli L, Danivi E, Rocha DM, Alves LI, Fukui RT, Silva MER. Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients. Arquivos Brasileiros de Endocrinologia & Metabologia. 2007 ; 51( 3): S101.[citado 2024 set. 19 ] -
Vancouver
Crisostomo LG, Gamberini M, Locoseli L, Danivi E, Rocha DM, Alves LI, Fukui RT, Silva MER. Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients. Arquivos Brasileiros de Endocrinologia & Metabologia. 2007 ; 51( 3): S101.[citado 2024 set. 19 ] - Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment
- Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
- Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Efeitos benéficos da associação de rosiglitazona ou metformina à glibenclamida no controle Glicêmico e risco cardiovascular
- Genetic Association of the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) and Type 1 Diabetes in Brazil
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study
- Non-Islet Autoantibodies (Non-IsletAAb): Prevalence and Association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients
- Resposta terapêutica ao uso de rosiglitazona ou nateglinida em diabéticos do tipo 2.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas